Migraine. Migraine
Conditions
Interventions
Intervention 1: Intervention group: In this group, patients are treated with 50 mg/kg L-carnitine daily. Intervention 2: Intervention group: In this group, patients are treated with 1 mg/kg Propranolo
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 15 Years
Inclusion criteria
Inclusion criteria: Children with migraine whose disease has recently been diagnosed with the International Headache Society (IHS) criteria. Not currently under any preventive treatment. Have a migraine headache for at least once a week.
Exclusion criteria
Exclusion criteria: Patients who have more than four headache attacks in a month (severe migraines)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache severity. Timepoint: Two weeks, one month, three months after begining of treatment. Method of measurement: Pediatric Migraine Disability Assessment Scale.;Headache frequency. Timepoint: Two weeks, one month, three months after begining of treatment. Method of measurement: interview.;Headache duration. Timepoint: Two weeks, one month, three months after begining of treatment. Method of measurement: Interview. | — |
Secondary
| Measure | Time frame |
|---|---|
| Medication side effects. Timepoint: Two weeks, one month, three months after begining of treatment. Method of measurement: Physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLaya Amini
Esfahan University of Medical Sciences
Outcome results
None listed